Sarepta Therapeutics (SRPT) Gains from Investment Securities (2010 - 2026)
Sarepta Therapeutics' quarterly Gains from Investment Securities came in at $1.3 million in Q1 2026, down 75.38% year-on-year from $5.2 million in Q1 2025, and down 93.56% quarter-over-quarter from $20.0 million in Q4 2025.
Sarepta Therapeutics has reported Gains from Investment Securities for 17 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 75.38% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $21.9 million (down 8.92% YoY), and the FY2025 full-year result was $488192.0, down 94.51% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $1.3 million, down from $20.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $80.2 million in Q4 2023, with the low at -$13.1 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is $7.1 million, with a median of $1.1 million recorded in 2023.
- Year-over-year, Gains from Investment Securities jumped 4774955.56% in 2022 and tumbled 566.09% in 2024.
- Tracing SRPT's Gains from Investment Securities over 5 years: stood at -$13.1 million in 2022, then surged by 710.65% to $80.2 million in 2023, then sank by 70.39% to $23.7 million in 2024, then declined by 15.75% to $20.0 million in 2025, then tumbled by 93.56% to $1.3 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.3 million (Q1 2026), $20.0 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 20.01 Mn |
| Dec 31, 2025 | 20.01 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Sep 30, 2025 | 5.19 Mn |
| Jun 30, 2025 | -4.59 Mn |
| Jun 30, 2025 | -4.59 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 23.75 Mn |
| Dec 31, 2024 | 23.75 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | -5.17 Mn |
| Jun 30, 2024 | -5.17 Mn |
| Mar 31, 2024 | 275,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 80.20 Mn |
| Dec 31, 2023 | 80.20 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | -13.13 Mn |
| Dec 31, 2022 | -13.13 Mn |
| Sep 30, 2022 | 925,167.00 |
| Sep 30, 2022 | 925,167.00 |
| Jun 30, 2022 | 859,510.00 |
| Jun 30, 2022 | 859,510.00 |
| Mar 31, 2022 | 712,435.00 |
| Mar 31, 2022 | 712,435.00 |
| Dec 31, 2021 | -4.46 Mn |
| Dec 31, 2021 | -4.46 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Jun 30, 2021 | 18.00 |
| Jun 30, 2021 | 18.00 |
| Mar 31, 2021 | -2.69 Mn |
| Mar 31, 2021 | -2.69 Mn |
| Dec 31, 2020 | 710,000.00 |
| Dec 31, 2020 | 710,000.00 |
| Sep 30, 2020 | 592,867.00 |
| Sep 30, 2020 | 592,867.00 |
| Jun 30, 2020 | 44,527.00 |
| Jun 30, 2020 | 44,527.00 |
| Mar 31, 2020 | 498,910.00 |
| Mar 31, 2020 | 498,910.00 |
| Dec 31, 2019 | 110.60 Mn |
| Dec 31, 2019 | 110.60 Mn |
| Sep 30, 2019 | 34,000.00 |
| Sep 30, 2019 | 34,000.00 |
| Jun 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 81,000.00 |
| Mar 31, 2019 | -88,000.00 |
| Mar 31, 2019 | -88,000.00 |
| Dec 31, 2018 | -4.03 Mn |
| Dec 31, 2018 | -4.03 Mn |
| Sep 30, 2018 | 27,000.00 |
| Sep 30, 2018 | 27,000.00 |
| Jun 30, 2018 | 45,000.00 |
| Jun 30, 2018 | 45,000.00 |
| Mar 31, 2018 | 150,725.00 |
| Mar 31, 2018 | 150,725.00 |
| Dec 31, 2017 | 8.81 Mn |
| Dec 31, 2017 | 8.81 Mn |
| Sep 30, 2017 | 181,029.00 |
| Sep 30, 2017 | 181,029.00 |
| Jun 30, 2017 | 335,000.00 |
| Jun 30, 2017 | 335,000.00 |
| Mar 31, 2017 | 156,029.00 |
| Mar 31, 2017 | 156,029.00 |
| Dec 31, 2016 | 5.44 Mn |
| Dec 31, 2016 | 5.44 Mn |
| Sep 30, 2016 | 71,925.00 |
| Sep 30, 2016 | 71,925.00 |
| Jun 30, 2016 | 25,775.00 |
| Jun 30, 2016 | 25,775.00 |
| Mar 31, 2016 | 25,775.00 |
| Mar 31, 2016 | 25,775.00 |
| Dec 31, 2015 | 6.52 Mn |
| Dec 31, 2015 | 6.52 Mn |
| Sep 30, 2015 | 65,000.00 |
| Sep 30, 2015 | 65,000.00 |
| Jun 30, 2015 | 110,783.00 |
| Jun 30, 2015 | 110,783.00 |
| Mar 31, 2015 | 6,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Sep 30, 2014 | -4.26 Mn |
| Sep 30, 2014 | -4.26 Mn |
| Jun 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Mar 31, 2014 | 3.25 Mn |
| Mar 31, 2014 | 3.25 Mn |
| Dec 31, 2013 | -23.98 Mn |
| Dec 31, 2013 | -23.98 Mn |
| Sep 30, 2013 | 58,116.00 |
| Sep 30, 2013 | 58,116.00 |
| Jun 30, 2013 | 1.95 Mn |
| Jun 30, 2013 | 1.95 Mn |
| Mar 31, 2013 | 2.69 Mn |
| Mar 31, 2013 | 2.69 Mn |
| Dec 31, 2012 | 51.78 Mn |
| Dec 31, 2012 | 51.78 Mn |
| Sep 30, 2012 | 42.72 Mn |
| Sep 30, 2012 | 42.72 Mn |
| Jun 30, 2012 | -13.49 Mn |
| Jun 30, 2012 | -13.49 Mn |
| Mar 31, 2012 | 10.93 Mn |
| Mar 31, 2012 | 10.93 Mn |
| Dec 31, 2011 | 2.42 Mn |
| Dec 31, 2011 | 2.42 Mn |
| Dec 31, 2010 | 1.42 Mn |
| Dec 31, 2010 | 1.42 Mn |